MiR-183-5p is significantly upregulated in glioma samples and was found to specifically target the TUSC2 3′UTR, predicted using starBase, which results in inhibition of TUSC2 mRNA translation and TUSC2-mediated glioma suppression [94,96,97]. This evidence concerns the gene TUSC2 and central nervous system cancer.